-
1.发明申请STEROID COMPOUND FOR USE IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY 有权STEROID化合物用于治疗HEPATIC ENCEPHALOPATHYY公开(公告)号：US20170056416A1
公开(公告)日：2017-03-02
申请号：US15352035
申请日：2016-11-15
IPC分类号： A61K31/568 , A61K31/4375 , A61K45/06
CPC分类号： A61K31/568 , A61K31/198 , A61K31/216 , A61K31/437 , A61K31/4375 , A61K31/7016 , A61K45/06 , A61K2300/00
摘要： The present invention provides the steroidal compound 3□-ethynyl-3□-hydroxyandrostan-17-one oxime, or a pharmaceutically acceptable salt thereof, for use in treatment of hepatic encephalopathy.
摘要翻译： 本发明提供了用于治疗肝性脑病的甾族化合物3'-乙炔基-3□ - 羟基和雄甾烷-17-酮肟或其药学上可接受的盐。
-
公开(公告)号：US10342804B2
公开(公告)日：2019-07-09
申请号：US15716838
申请日：2017-09-27
IPC分类号： A61K45/06 , A61K31/198 , A61K31/216 , A61K31/437 , A61K31/568 , A61K31/4375 , A61K31/7016
摘要： The present invention provides the steroidal compound 3α-ethynyl-3β-hydroxyandrostan-17-one oxime, or a pharmaceutically acceptable salt thereof, for use in treatment of hepatic encephalopathy.
-
3.发明申请STEROID COMPOUND FOR USE IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY 审中-公开STEROID化合物用于治疗HEPATIC ENCEPHALOPATHYY公开(公告)号：US20160339040A1
公开(公告)日：2016-11-24
申请号：US15114972
申请日：2015-01-14
IPC分类号： A61K31/568 , A61K31/437 , A61K45/06
CPC分类号： A61K31/568 , A61K31/198 , A61K31/216 , A61K31/437 , A61K31/4375 , A61K31/7016 , A61K45/06 , A61K2300/00
摘要： The present invention provides the steroidal compound 3□-ethynyl-3□-hydroxyandrostan-17-one oxime, or a pharmaceutically acceptable salt thereof, for use in treatment of hepatic encephalopathy.
摘要翻译： 本发明提供了用于治疗肝性脑病的甾族化合物3'-乙炔基-3□ - 羟基和雄甾烷-17-酮肟或其药学上可接受的盐。
-
公开(公告)号：US20180015103A1
公开(公告)日：2018-01-18
申请号：US15716838
申请日：2017-09-27
IPC分类号： A61K31/568 , A61K31/7016 , A61K31/4375 , A61K31/437 , A61K31/216 , A61K45/06 , A61K31/198
CPC分类号： A61K31/568 , A61K31/198 , A61K31/216 , A61K31/437 , A61K31/4375 , A61K31/7016 , A61K45/06 , A61K2300/00
摘要： The present invention provides the steroidal compound 3α-ethynyl-3β-hydroxyandrostan-17-one oxime, or a pharmaceutically acceptable salt thereof, for use in treatment of hepatic encephalopathy.
-
公开(公告)号：US09801894B2
公开(公告)日：2017-10-31
申请号：US15352035
申请日：2016-11-15
IPC分类号： A61K31/568 , A61K31/4375 , A61K45/06 , A61K31/198 , A61K31/216 , A61K31/437 , A61K31/7016
CPC分类号： A61K31/568 , A61K31/198 , A61K31/216 , A61K31/437 , A61K31/4375 , A61K31/7016 , A61K45/06 , A61K2300/00
摘要： The present invention provides the steroidal compound 3□-ethynyl-3□-hydroxyandrostan-17-one oxime, or a pharmaceutically acceptable salt thereof, for use in treatment of hepatic encephalopathy.
-
-
-
-
搜索结果
5 条记录 (耗时 0.012 秒)
